This page is facial PLLA (poly-L-lactic acid) biostimulation under DRFK’s Anti-Aging programme, not the Sculptra-for-hair scalp protocol used elsewhere. Sculptra gradually recruits your own collagen for temple, cheek, and jawline support where volume loss is global rather than a single “line to fill”, a multi-session, dilute–place–massage rhythm with results that build over months.
DRFK Turkish Medical Center is located at Villa 2, Al Athar Street, Jumeirah 3, Dubai. The clinic is easily accessible from Jumeirah, Umm Suqeim, Al Safa, Business Bay, and Downtown Dubai within around 15 minutes via Sheikh Zayed Road, with on-site parking available.
PLLA works by neocollagenesis, it is not a water-binding gel. Initial volume is partly the fluid carrier; the cosmetic benefit emerges as collagen matures, often after the second and third visit in a plan.
Post-session massage reduces nodule risk when performed as taught. Nodules, though uncommon with proper technique, are managed medically, you receive written aftercare, not a social-media “optional” list.
With age, skin loses roughly 1% collagen per year — thinning, sagging, and a tired appearance follow. Sculptra's PLLA microparticles stimulate fibroblasts so your body produces its own type-1 collagen. Change builds gradually over weeks, so results look natural rather than "done overnight".
Sculptra at DRFK Jumeirah 3 is administered by Dr. Sedef Gökce Şenocak and Dr. Seda Erdoğan. Effect can last up to 2 years with a staged biostimulation protocol.
Lead specialist
General Practitioner & Medical Aesthetician
Medical Aesthetics
15+ years experience
DHA License No: 64970314-002
Dr. Sedef Şenocak, Full ProfileSpecialist training in regenerative therapies (collagen stimulators, PRP, exosomes); Canadian Board diplomate, DHA-licensed (64970314-002). Known for placing Sculptra at the centre of holistic rejuvenation plans.
Lead specialist
Dermatology Specialist
Dermatology
15+ years experience
DHA License No: 07420402-001
Dr. Seda Erdoğan, Full Profile15+ years as Consultant Dermatologist (DHA 07420402-001). Dermatological skin quality analysis identifies where Sculptra delivers the greatest benefit.
Sculptra is a poly-L-lactic acid (PLLA) biostimulatory injectable, not a filler. The critical distinction: fillers (HA-based) add immediate volume by occupying physical space. Sculptra deposits PLLA microparticles into the deep dermis and subcutis, triggering a foreign body response that stimulates fibroblast proliferation and new collagen Type I and III synthesis. The volume and structural improvement emerges gradually over 4–12 weeks as collagen builds, and lasts 2+ years as the collagen matrix persists long after the PLLA particles have biodegraded.
Sculptra is not the right choice for patients wanting immediate results, it is the right choice for patients wanting lasting structural improvement that looks like natural facial aging reversal rather than an obviously treated appearance.
Facial volume loss is not simply "fat going away." The dermis loses collagen at approximately 1% per year from the mid-20s. Thinner dermis means less structural support for the facial fat compartments above it, the cheek fat descends, temples hollow, nasolabial folds deepen, and the jawline softens, not because the face is dramatically losing fat, but because the collagen scaffold supporting the tissue has weakened.
HA filler treats the effect (replaces missing volume temporarily). Sculptra treats a component of the cause (rebuilds the collagen that was providing structural support), producing a more natural correction that improves progressively rather than appearing immediately and fading uniformly.
Key difference: Sculptra is a collagen biostimulator producing gradual, long-lasting structural improvement. Dermal fillers produce immediate volumetric addition lasting 6–18 months.
| Sculptra (PLLA) | Dermal Fillers (HA) | |
|---|---|---|
| Mechanism | Collagen biostimulation | Immediate volume addition |
| Effect onset | Gradual, 4–12 weeks | Immediate |
| Duration | 2+ years | 6–18 months |
| Appearance | Natural gradual improvement | Immediate visible change |
| Reversibility | Not reversible | Hyaluronidase reversible |
| Best for | Structural volume loss, skin quality | Focal volume, immediate correction |
| Sessions | 1–3 | 1 (with maintenance) |
Ideal candidates: Patients with progressive facial volume loss preferring gradual natural-looking restoration. Patients who have experienced short filler duration (rapid metabolisers) wanting longer-lasting correction. Patients in their 40s–60s seeking structural improvement without surgical intervention. Patients specifically wanting to avoid an immediately "done" appearance.
Not suitable for Sculptra: Patients wanting immediate visible correction (fillers are more appropriate). Active inflammatory skin conditions at the treatment site. PLLA hypersensitivity history. Areas requiring fine line correction (Sculptra works in deep dermis/subcutis, not surface lines).
| Assessment | Purpose |
|---|---|
| Facial Volume Mapping | Cheek, temple, jawline, perioral, volume deficit quantification |
| Skin Quality Assessment | Dermal thickness, collagen integrity, skin laxity |
| Patient Expectation Alignment | Confirming gradual-onset preference, critical for appropriateness |
| Sculptra vs HA Filler Decision | Urgency and immediacy of desired result determines which is correct |
| Medical History | PLLA sensitivity, autoimmune conditions |
The mid-face fat compartments that deflate most visibly with age, producing the gaunt, tired appearance of mid-face volume loss. Sculptra injection in the deep subcutaneous layer of the cheek, 2–3 sessions spaced 4–6 weeks, rebuilds the collagen support structure beneath the cheek fat, producing progressive, natural-looking fullness improving over 3–6 months.
The temporal fossa, the area above the cheekbone and beside the eye, hollows significantly from the early 40s, producing the "skeletonised" appearance. Sculptra in the deep temporal fat pad, beneath the fascia, rebuilds the volume that restores the smooth temporal convexity of youth.
Sculptra along the mandibular border stimulates collagen remodelling that improves the structural definition of the jawline and supports the overlying soft tissue against gravitational descent. Used in combination with HA filler for patients requiring both structural support and immediate volume.
Standard programme: 2–3 sessions spaced 4–6 weeks apart. Volume per session determined by facial assessment. The 5×5×5 massage protocol is mandatory after every Sculptra session, massage the treatment area for 5 minutes, 5 times daily, for 5 days.
| Step | What Happens |
|---|---|
| 01, Consultation | Volume mapping, expectation alignment, Sculptra vs filler decision |
| 02, Session 1 | PLLA injection with topical anaesthesia; 5×5×5 massage instruction |
| 03, Weeks 1–4 | Mild swelling resolves; PLLA stimulating fibroblasts |
| 04, Session 2 (Week 4–6) | Second injection; cumulative stimulation |
| 05, Month 2–3 | Volume improvement visible; progressive collagen building |
| 06, Month 4–6 | Full structural improvement; final result assessment |
| 07, Maintenance | Single session at 18–24 months |
Weeks 1–4: No visible change (collagen synthesis initiating). Month 1–2: Early firmness improvement. Month 2–4: Progressive volume and structural improvement. Month 4–6: Full Sculptra effect, natural, gradual facial rejuvenation. Duration: 2+ years.
Recovery: Mild swelling at injection sites for 2–5 days. No downtime. Return to normal activity same day. Mandatory 5×5×5 massage, 5 minutes, 5 times daily, for 5 days after each session.
Targets global volume loss, not every fine line; photos for baseline; realistic session count and intervals.
Sterile reconstitution and placement; 5-5-5 style massage when prescribed by your team.
Assess at 4–6 week intervals; top-up vials only when tissue response and goals align.
Avoid sunbeds and harsh peels before laser or device sessions unless cleared.
List all medications and previous fillers/surgery for safety screening.
Plan social downtime: mild swelling is common 24–72h after injectables.
Medically reviewed at DRFK | Dr. Sedef Şenocak & Dr. Seda Erdoğan | Last updated: April 2026
Every day: 9:00 AM – 6:00 PM
Villa 2 Al Athar Street, Jumeirah 3, Dubai, United Arab Emirates
